21993244 |
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y,
Grabocka, E,
Bar-Sagi, D
|
Nat. Rev. Cancer |
2011 |
16702958 |
Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein
Brummer, T,
Martin, P,
Herzog, S,
Misawa, Y,
Daly, RJ,
Reth, M
|
Oncogene |
2006 |
21514245 |
c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma
Blasco, RB,
Francoz, S,
Santamaría, D,
Cañamero, M,
Dubus, P,
Charron, J,
Baccarini, M,
Barbacid, M
|
Cancer Cell |
2011 |
16364920 |
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization
Garnett, MJ,
Rana, S,
Paterson, H,
Barford, D,
Marais, R
|
Mol. Cell |
2005 |
23352452 |
Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling
Freeman, AK,
Ritt, DA,
Morrison, DK
|
Mol. Cell |
2013 |
20141835 |
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
Heidorn, SJ,
Milagre, C,
Whittaker, S,
Nourry, A,
Niculescu-Duvas, I,
Dhomen, N,
Hussain, J,
Reis-Filho, JS,
Springer, CJ,
Pritchard, C,
Marais, R
|
Cell |
2010 |
22589270 |
A comprehensive survey of Ras mutations in cancer
Prior, IA,
Lewis, PD,
Mattos, C
|
Cancer Res. |
2012 |
20179705 |
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikakos, PI,
Zhang, C,
Bollag, G,
Shokat, KM,
Rosen, N
|
Nature |
2010 |
22510884 |
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling
Röring, M,
Herr, R,
Fiala, GJ,
Heilmann, K,
Braun, S,
Eisenhardt, AE,
Halbach, S,
Capper, D,
von Deimling, A,
Schamel, WW,
Saunders, DN,
Brummer, T
|
EMBO J. |
2012 |
22043453 |
C-Raf is required for the initiation of lung cancer by K-Ras(G12D)
Karreth, FA,
Frese, KK,
DeNicola, GM,
Baccarini, M,
Tuveson, DA
|
Cancer Discov |
2011 |
17018604 |
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling
Dumaz, N,
Hayward, R,
Martin, J,
Ogilvie, L,
Hedley, D,
Curtin, JA,
Bastian, BC,
Springer, C,
Marais, R
|
Cancer Res. |
2006 |
20130576 |
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Hatzivassiliou, G,
Song, K,
Yen, I,
Brandhuber, BJ,
Anderson, DJ,
Alvarado, R,
Ludlam, MJ,
Stokoe, D,
Gloor, SL,
Vigers, G,
Morales, T,
Aliagas, I,
Liu, B,
Sideris, S,
Hoeflich, KP,
Jaiswal, BS,
Seshagiri, S,
Koeppen, H,
Belvin, M,
Friedman, LS,
Malek, S
|
Nature |
2010 |
24202393 |
Tumor adaptation and resistance to RAF inhibitors
Lito, P,
Rosen, N,
Solit, DB
|
Nat. Med. |
2013 |
23453624 |
Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer
Eser, S,
Reiff, N,
Messer, M,
Seidler, B,
Gottschalk, K,
Dobler, M,
Hieber, M,
Arbeiter, A,
Klein, S,
Kong, B,
Michalski, CW,
Schlitter, AM,
Esposito, I,
Kind, AJ,
Rad, L,
Schnieke, AE,
Baccarini, M,
Alessi, DR,
Rad, R,
Schmid, RM,
Schneider, G,
Saur, D
|
Cancer Cell |
2013 |